Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 11, 2007, Pages 2196-2200

  Yoon, Seo Hyun ^a   Han, Eun Jung ^a   Sung, Jong Hwan ^b   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Ilhwa Pharmaceutical CO LTD   (South Korea)

Author keywords

Anti hyperglycemic effect; Combination therapy; Compound K; db db mice; Metformin

Indexed keywords

COMPOUND K; EOSIN; GLUCOSE; HEMATOXYLIN; INSULIN; METFORMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MONOTHERAPY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GINSENOSIDES; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, MUTANT STRAINS; RANDOM ALLOCATION; TIME FACTORS;

EID: 36048962905     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.2196     Document Type: Article

References (32)

1. Warren R. E., Diabetes Res. Clin. Pract., 65S, S3-S8 (2004).
2. Diabetes Control and Complications Trial Research Group, N. Engl. J. Med., 329, 977-986 (1999).
3. DeFronzo R. A., Ann. Intern. Med., 131, 281-303 (1999).
4. LaSalle J. R., Cross L. B., Am. J. Manag. Care, 12, S369-S381 (2006).
5. Yamazaki K., Inoue T., Yasuda N., Sato Y., Nagakura T., Takenaka O., Clark R., Saeki T., Tanaka I., J. Pharmacol. Sci., 104, 29-38 (2007).
6. Takasaki K., Nakajima T., Ueno K., Nomoto Y., Higo K., J. Pharmacol. Sci., 95, 292-293 (2004).
7. Attele A. S., Wu J. A., Yuan C. S., Biochem. Pharmacol., 58, 1685-1693 (1999).
8. Yokozawa T., Kobayashi T., Oura H., Kawashima Y., Chem. Pharm. Bull., 33, 869-872 (1985).
9. Attele A. S., Zhou Y. P., Xie J. T., Wu J. A., Zhang L., Dey L., Pugh W., Rue P. A., Polonsky K. S., Yuan C. S., Diabetes, 51, 1851-1858 (2002).
10. Xie J. T., Mehendale S. R., Li X., Quigg R., Wang X., Wang C. Z., Wu J. A., Aung H. H., Rue P. A., Bell G. I., Yuan C. S., Biochim. Biophys. Acta, 1740, 319-325 (2005).
11. Vuksan V., Sievenpiper J. L., Nutr. Metab. Cardiovasc. Dis., 15, 149-160 (2005).
12. Akao T., Kanaoka M., Kobashi K., Biol. Pharm. Bull., 21, 245-249 (1998).
13. Tawab M. A., Bahr U., Karas M., Wurglics M., Drug Metab. Dispos., 31, 1065-1071 (2003).
14. Wakabayashi C., Murakami K., Hasegawa H., Murata J., Saiki L., Biochem. Biophys. Res. Commun., 246, 725-730 (1998).
15. Lee H. U., Bae E. A., Han M. J., Kim N. J., Kim D. H., Liver Int., 25, 1069-1073 (2005).
16. Lee S. J., Ko W. G., Kim J. H., Sung J. H., Moon C. K., Lee B. H., Biochem. Pharmacol., 60, 677-685 (2000).
17. Lee S. J., Sung J. H., Lee S. J., Moon C. K., Lee B. H., Cancer Lett., 144, 39-43 (1999).
18. Shin Y. W., Kim D. H., J. Pharmacol. Sci., 99, 83-88 (2005).
19. American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control, Endocr. Pract., 8 (Suppl. 1), 5-11 (2002).
20. Inzucchi S. E., JAMA, 287, 360-372 (2002).
21. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. L., Diabetologia, 28, 412-419 (1985).
22. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J. E., N. Engl. J. Med., 333, 550-554 (1995).
23. Wiernsperger N. F., Bailey C. J., Drugs, 58, 31-39 (1999).
24. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., J. Clin. Invest., 108, 1167-1174 (2001).
25. Owen M. R., Doran E., Halestrap A. P., Biochem. J., 348, 607-614 (2000).
26. Guigas B., Detaille D., Chauvin C., Batandier C., De Olivera F., Fontaine E., Leverve X., Biochem. J., 382, 877-884 (2004).
27. Holland W., Morrison T., Chang Y., Wiernsperger N., Stith B. J., Biochem. Pharmacol., 67, 2081-2091 (2004).
28. Zimmet P., Alberti K. G. M. M., Shaw J., Nature (London), 414, 782-787 (2000).
29. Kahn S. E., Diabetologia, 46, 3-19 (2003).
30. Ceriello A., Diabetes Metab. Res. Rev., 16, 125-132 (2000).
31. el-Hassan A. Y., Ibrahim E. M., al-Mulhim F. A., Nabhan A. A., Chammas M. Y., Br. J. Radiol., 65, 774-778 (1992).
32. Lin H. Z., Yang S. Q., Chuckaree C., Kuhajda F., Ronnet G., Diehl A. M., Nature Med., 6, 998-1003 (2000).